These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28874103)

  • 1. Neuroendocrine Regulation of Food Intake in Polycystic Ovary Syndrome.
    Romualdi D; Immediata V; De Cicco S; Tagliaferri V; Lanzone A
    Reprod Sci; 2018 May; 25(5):644-653. PubMed ID: 28874103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.
    Moran LJ; Noakes M; Clifton PM; Wittert GA; Tomlinson L; Galletly C; Luscombe ND; Norman RJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3337-44. PubMed ID: 15240612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin, polycystic ovaries and polycystic ovary syndrome.
    Jacobs HS; Conway GS
    Hum Reprod Update; 1999; 5(2):166-71. PubMed ID: 10336020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of leptin in reproduction, pregnancy and polycystic ovary syndrome: consensus knowledge and recent developments.
    Vázquez MJ; Romero-Ruiz A; Tena-Sempere M
    Metabolism; 2015 Jan; 64(1):79-91. PubMed ID: 25467843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G; Davidson CR; Billings DL
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins.
    Walters KA; Gilchrist RB; Ledger WL; Teede HJ; Handelsman DJ; Campbell RE
    Trends Endocrinol Metab; 2018 Dec; 29(12):841-852. PubMed ID: 30195991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition, insulin and polycystic ovary syndrome.
    Franks S; Robinson S; Willis DS
    Rev Reprod; 1996 Jan; 1(1):47-53. PubMed ID: 9414438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
    Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
    Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B
    Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine control of food intake.
    Valassi E; Scacchi M; Cavagnini F
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
    Douglas CC; Norris LE; Oster RA; Darnell BE; Azziz R; Gower BA
    Fertil Steril; 2006 Aug; 86(2):411-7. PubMed ID: 16762348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of ghrelin and leptin in the control of reproductive function.
    Tena-Sempere M
    Neuroendocrinology; 2007; 86(3):229-41. PubMed ID: 17851226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome.
    Barr S; Hart K; Reeves S; Sharp K; Jeanes YM
    Eur J Clin Nutr; 2011 Oct; 65(10):1126-32. PubMed ID: 21629269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Impairments of Polycystic Ovary Syndrome.
    Ruddenklau A; Campbell RE
    Endocrinology; 2019 Oct; 160(10):2230-2242. PubMed ID: 31265059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.
    Rondanelli M; Perna S; Faliva M; Monteferrario F; Repaci E; Allieri F
    Arch Gynecol Obstet; 2014 Dec; 290(6):1079-92. PubMed ID: 25200687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.